Table 1.

Base Case Cost-Effectiveness.

Treatment option	Expected Effect	Expected Total Cost	Expected Treatment Cost	Expected Complication Cost
FD	0.638	$17,642	$16,868	$774
MSC allogeneic	0.66	$13,536	$13,265	$271
MSC autologous	0.66	$7,536	$7,265	$271
Compared to FD
MSC allogeneic	0.022	$4,106 savings	$3,603 savings	$503 savings
MSC autologous	0.022	$10,106 savings	$9,603 savings	$503 savings

In conclusion, our study demonstrates that MSCs are more cost effective than FD for refractory pCD in an academic medical center.